180 Life Sciences Corp. (NASDAQ: ATNF) is 27.84% higher on its value in year-to-date trading and has touched a low of $1.90 and a high of $11.50 in the current 52-week trading range. The ATNF stock was last observed hovering at around $3.49 in the last trading session, with the day’s gains setting it 0.35%.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $3.84, the stock is 34.38% and 41.73% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.91 million and changing 10.15% at the moment leaves the stock -55.33% off its SMA200. ATNF registered -65.62% loss for a year compared to 6-month loss of -67.98%. The firm has a 50-day simple moving average (SMA 50) of $2.7322 and a 200-day simple moving average (SMA200) of $4.4116.
The stock witnessed a 25.99% gain in the last 1 month and extending the period to 3 months gives it a -68.33%, and is 12.94% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.15% over the week and 11.03% over the month.
Distance from 52-week low is 102.34% and -66.57% from its 52-week high.
180 Life Sciences Corp. (ATNF) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for 180 Life Sciences Corp. (ATNF) is a “-“. 0 analysts offering their recommendations for the stock, where 0 rate it as a Hold and 0 think it is a “Overweight”. 0 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
The EPS is expected to shrink by -130.90% this year.
180 Life Sciences Corp. (ATNF) Top Institutional Holders
6 institutions hold shares in 180 Life Sciences Corp. (ATNF), with 2.96M shares held by insiders accounting for 57.18% while institutional investors hold 11.24% of the company’s shares. The shares outstanding are 5.18M, and float is at 0.97M with Short Float at 14.54%. Institutions hold 4.81% of the Float.
180 Life Sciences Corp. (ATNF) Insider Activity
A total of 15 insider transactions have happened at 180 Life Sciences Corp. (ATNF) in the last six months, with sales accounting for 11 and purchases happening 4 times. The most recent transaction is an insider sale by KRAUSS MARLENE, the company’s 10% Owner. SEC filings show that KRAUSS MARLENE sold 16,506 shares of the company’s common stock on Dec 17 at a price of $2.48 per share for a total of $40880.0. Following the sale, the insider now owns 2.01 million shares.
180 Life Sciences Corp. disclosed in a document filed with the SEC on Dec 15 that KRAUSS MARLENE (10% Owner) sold a total of 17,877 shares of the company’s common stock. The trade occurred on Dec 15 and was made at $2.40 per share for $42905.0. Following the transaction, the insider now directly holds 2.54 million shares of the ATNF stock.
Still, SEC filings show that on Dec 14, KRAUSS MARLENE (10% Owner) disposed off 10,000 shares at an average price of $2.45 for $24500.0. The insider now directly holds 2,561,553 shares of 180 Life Sciences Corp. (ATNF).